About us
Research Library
Company Pages
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
Redx Pharma
Scancell
Contact us
More Company News
Allergy Therapeutics
Phase I VLP Peanut PROTECT trial progress
26 Sep 2023
Read More
Allergy Therapeutics
Satisfaction of FDI clearance conditions
22 Sep 2023
Read More
Allergy Therapeutics
Trading update
10 Aug 2023
Read More
Allergy Therapeutics
Appointment of CFO
10 Jul 2023
Read More
Allergy Therapeutics
Interim H123 results and lifting of suspension in trading
19 Jun 2023
Read More
Allergy Therapeutics
Publication of 2022 annual report and accounts
19 Jun 2023
Read More
Allergy Therapeutics
Data at EAACI
09 Jun 2023
Read More
Allergy Therapeutics
Skin-prick testing completes in PROTECT trial
19 Apr 2023
Read More
Allergy Therapeutics
Statement regarding possible mandatory cash offer
06 Apr 2023
Read More
Allergy Therapeutics
£40.75 million facility with equity financing
06 Apr 2023
Read More
1
2
3
4
5
Return to Allergy Therapeutics
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About us
Research Library
Company Pages
â–¼
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
Redx Pharma
Scancell
Contact us